155 related articles for article (PubMed ID: 26027240)
1. [X-ray, laboratory, and functional parallels in intrathoracic sarcoidosis].
Vizel IY; Vizel AA; Shaimuratov RI
Ter Arkh; 2015; 87(3):48-52. PubMed ID: 26027240
[TBL] [Abstract][Full Text] [Related]
2. Optimal scoring of serial change on chest radiography in sarcoidosis.
Zappala CJ; Desai SR; Copley SJ; Spagnolo R; Cramer D; Sen D; Alam SM; du Bois RM; Hansell DM; Wells AU
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):130-8. PubMed ID: 22117504
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of C-reactive protein and clinically relevant baseline variables in sarcoidosis.
McDonnell MJ; Saleem MI; Wall D; Gilmartin JJ; Rutherford RM; O'Regan A
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):331-340. PubMed ID: 28079845
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of individual variables in the monitoring of long-term change in pulmonary sarcoidosis as judged by serial high-resolution CT scan data.
Zappala CJ; Desai SR; Copley SJ; Spagnolo P; Sen D; Alam SM; du Bois RM; Hansell DM; Wells AU
Chest; 2014 Jan; 145(1):101-107. PubMed ID: 24051950
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis.
Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503
[TBL] [Abstract][Full Text] [Related]
6. [Dynamics of clinical, X-ray and functional data during treatment of patients with sarcoidosis].
Vizel IY; Vizel AA
Klin Med (Mosk); 2017; 95(1):60-5. PubMed ID: 30299068
[TBL] [Abstract][Full Text] [Related]
7. Functional significance of the decreased attenuation sign on expiratory CT in pulmonary sarcoidosis : report of four cases.
Fazzi P; Sbragia P; Solfanelli S; Troilo S; Giuntini C
Chest; 2001 Apr; 119(4):1270-4. PubMed ID: 11296199
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary sarcoidosis: comparison of findings of inspiratory and expiratory high-resolution CT and pulmonary function tests between smokers and nonsmokers.
Terasaki H; Fujimoto K; Müller NL; Sadohara J; Uchida M; Koga T; Aizawa H; Hayabuchi N
AJR Am J Roentgenol; 2005 Aug; 185(2):333-8. PubMed ID: 16037502
[TBL] [Abstract][Full Text] [Related]
9. Opposite behavior of plasma levels surfactant protein type B and receptor for advanced glycation end products in pulmonary sarcoidosis.
Magrì D; Mariotta S; Banfi C; Ricotta A; Onofri A; Ricci A; Pisani L; Cauti FM; Ghilardi S; Agostoni P
Respir Med; 2013 Oct; 107(10):1617-24. PubMed ID: 23948664
[TBL] [Abstract][Full Text] [Related]
10. Exercise and resting pulmonary function in sarcoidosis.
Karetzky M; McDonough M
Sarcoidosis Vasc Diffuse Lung Dis; 1996 Mar; 13(1):43-9. PubMed ID: 8865409
[TBL] [Abstract][Full Text] [Related]
11. Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis.
Kuipers AF; Alberts C; Roos CM; van der Schoot JB; Jansen HM
Sarcoidosis; 1993 Mar; 10(1):36-40. PubMed ID: 8134713
[TBL] [Abstract][Full Text] [Related]
12. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension.
Sulica R; Teirstein AS; Kakarla S; Nemani N; Behnegar A; Padilla ML
Chest; 2005 Sep; 128(3):1483-9. PubMed ID: 16162747
[TBL] [Abstract][Full Text] [Related]
13. The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients.
Cameli P; Gonnelli S; Bargagli E; d'Alessandro M; Bergantini L; Favetta V; Tomai Pitinca MD; Lisi E; Refini RM; Pieroni M; Sestini P; Caffarelli C
Respiration; 2020; 99(3):207-212. PubMed ID: 32114588
[TBL] [Abstract][Full Text] [Related]
14. Ultrasonographic evaluation of lung parenchyma involvement in sarcoidosis.
Doğan C; Kıral N; Parmaksız ET; Çağlayan B; Sağmen SB; Salepçi B; Fidan A; Cömert SŞ
Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(2):130-140. PubMed ID: 32476946
[TBL] [Abstract][Full Text] [Related]
15. Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients.
Piotrowski WJ; Kiszałkiewicz J; Górski P; Antczak A; Górski W; Pastuszak-Lewandoska D; Migdalska-Sęk M; Domańska-Senderowska D; Nawrot E; Czarnecka KH; Kurmanowska Z; Brzeziańska-Lasota E
BMC Immunol; 2015 Oct; 16():58. PubMed ID: 26445225
[TBL] [Abstract][Full Text] [Related]
16. Severity of pulmonary involvement and (18)F-FDG PET activity in sarcoidosis.
Mostard RL; Verschakelen JA; van Kroonenburgh MJ; Nelemans PJ; Wijnen PA; Vöö S; Drent M
Respir Med; 2013 Mar; 107(3):439-47. PubMed ID: 23261309
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the modified shuttle walk test and cardiopulmonary exercise test in sarcoidosis.
de Boer S; Kolbe J; Wilsher ML
Respirology; 2014 May; 19(4):604-7. PubMed ID: 24666931
[TBL] [Abstract][Full Text] [Related]
18. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity.
Wallaert B; Talleu C; Wemeau-Stervinou L; Duhamel A; Robin S; Aguilaniu B
Respiration; 2011; 82(6):501-8. PubMed ID: 21934275
[TBL] [Abstract][Full Text] [Related]
19. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage.
Viskum K; Vestbo J
Eur Respir J; 1993 Mar; 6(3):349-53. PubMed ID: 8472824
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme. III. Changes in serum level as an indicator of disease activity in untreated sarcoidosis.
Selroos O; Grönhagen-Riska C
Scand J Respir Dis; 1979 Dec; 60(6):328-36. PubMed ID: 231819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
